These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 8443697

  • 1. Long- and short-term side effects and safety of calcitonin in man: a prospective study.
    Wimalawansa SJ.
    Calcif Tissue Int; 1993 Feb; 52(2):90-3. PubMed ID: 8443697
    [Abstract] [Full Text] [Related]

  • 2. Treatment of Paget's disease of bone with salmon calcitonin nasal spray.
    Gagel RF, Logan C, Mallette LE.
    J Am Geriatr Soc; 1988 Nov; 36(11):1010-4. PubMed ID: 3171038
    [Abstract] [Full Text] [Related]

  • 3. Paget's bone disease: response to human calcitonin in patients resistant to salmon calcitonin.
    Rojanasathit S, Rosenberg E, Haddad JG.
    Lancet; 1974 Dec 14; 2(7894):1412-5. PubMed ID: 4140329
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of the acute biological action of injectable salmon calcitonin and an injectable and oral calcitonin analogue.
    Devogelaer JP, Azria M, Attinger M, Abbiati G, Castiglioni C, Nagant de Deuxchaisnes C.
    Calcif Tissue Int; 1994 Jul 14; 55(1):71-3. PubMed ID: 7922793
    [Abstract] [Full Text] [Related]

  • 5. A comparison of the acute effects of subcutaneous and intranasal calcitonin.
    O'Doherty DP, Bickerstaff DR, McCloskey EV, Atkins R, Hamdy NA, Kanis JA.
    Clin Sci (Lond); 1990 Feb 14; 78(2):215-9. PubMed ID: 2155751
    [Abstract] [Full Text] [Related]

  • 6. [Hypocalcemia induced in patients with Paget's disease by nasal salmon calcitonin. Effects of anti-calcitonin salmine antibodies].
    Reginster JY, Almer S, Gaspar S, Albert A, Deroisy R, Franchimont P.
    Rev Rhum Mal Osteoartic; 1989 Jun 14; 56(7):563-7. PubMed ID: 2756322
    [No Abstract] [Full Text] [Related]

  • 7. [Treatment of Paget's disease of bone with salmon calcitonin (author's transl)].
    Kuhlencordt F, Ringe JD, Kruse HP.
    Dtsch Med Wochenschr; 1981 Nov 27; 106(48):1620-3. PubMed ID: 7308002
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of the acute effect of the intranasal and intramuscular administration of salmon calcitonin in Paget's disease.
    González D, Vega E, Ghiringhelli G, Mautalen C.
    Calcif Tissue Int; 1987 Dec 27; 41(6):313-5. PubMed ID: 3124939
    [Abstract] [Full Text] [Related]

  • 10. [On the treatment of the osteodystrophia deformans (Paget's disease) with synthetic salmon calcitonin (author's transl)].
    Trzenschik K, Schmidt UJ, Abendroth K, Ansorg H, Graner H, Lindenhayn K, Schramm G, Kalbe I.
    Z Alternsforsch; 1978 Dec 27; 33(5):441-51. PubMed ID: 570764
    [Abstract] [Full Text] [Related]

  • 11. Clinical efficacy of salmon calcitonin in Paget's disease of bone.
    Singer FR.
    Calcif Tissue Int; 1991 Dec 27; 49 Suppl 2():S7-8. PubMed ID: 1933617
    [Abstract] [Full Text] [Related]

  • 12. Salmon-calcitonin nasal spray in Paget's disease of bone: preliminary results in five patients.
    Reginster JY, Albert A, Franchimont P.
    Calcif Tissue Int; 1985 Dec 27; 37(6):577-80. PubMed ID: 3937575
    [Abstract] [Full Text] [Related]

  • 13. Treatment of Paget's disease of bone with a combination of intranasal salmon calcitonin and oral calcium and thiazide.
    Evans RA, Somers NM, Dunstan CR, Hills E, Evans M.
    Calcif Tissue Int; 1991 Sep 27; 49(3):164-7. PubMed ID: 1933580
    [Abstract] [Full Text] [Related]

  • 14. [Therapeutic effect of synthetic calcitonin from salmon in Paget's disease and in osteoporosis].
    Caniggia A, Gennari C, Vattimo A, Nardi P, Francini G.
    Clin Ter; 1977 Aug 15; 82(3):213-26. PubMed ID: 562244
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of Paget's disease of bone with synthetic salmon calcitonin.
    Kanis JA, Horn DB, Scott RD, Strong JA.
    Br Med J; 1974 Sep 21; 3(5933):727-31. PubMed ID: 4472416
    [Abstract] [Full Text] [Related]

  • 16. [Salmon calcitonin nasal spray in the treatment of Paget's disease].
    Giustina A, Macca C, Bossoni S, Romanelli G, Zuccato F.
    Recenti Prog Med; 1989 Nov 21; 80(11):599-602. PubMed ID: 2623325
    [Abstract] [Full Text] [Related]

  • 17. Synthetic human calcitonin in refractory Paget's disease of bone.
    Altman RD, Collins-Yudiskas B.
    Arch Intern Med; 1987 Jul 21; 147(7):1305-8. PubMed ID: 3111398
    [Abstract] [Full Text] [Related]

  • 18. Response of Paget's disease to porcine and salmon calcitonins: effects of long-term treatment.
    DeRose J, Singer FR, Avramides A, Flores A, Dziadiw R, Baker RK, Wallach S.
    Am J Med; 1974 Jun 21; 56(6):858-66. PubMed ID: 4857531
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical and therapeutic data on the use of synthetic salmon calcitonin in Sudeck's syndrome, Paget's disease and migrant osteoporosis].
    Maggi G.
    Clin Ter; 1978 May 31; 85(4):375-93. PubMed ID: 668274
    [No Abstract] [Full Text] [Related]

  • 20. Effect of calcitonin treatment on the natural course of bone demineralization in Paget's disease.
    Toh SH, Claunch BC, Brown PH.
    J Clin Endocrinol Metab; 1983 Feb 31; 56(2):405-9. PubMed ID: 6822644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.